• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

Pfizer

Anonymous board for Pfizer.
Replies
3
Views
1K
Anonymous
Replies
2
Views
573
Anonymous
Replies
20
Views
1K
Anonymous
Replies
11
Views
2K
Anonymous
Replies
22
Views
3K
Anonymous
Replies
37
Views
3K
Anonymous
Replies
4
Views
1K
Anonymous
Replies
2
Views
1K
Anonymous
Replies
30
Views
2K
Anonymous
Replies
61
Views
6K
Anonymous
Replies
11
Views
923
Anonymous
Replies
12
Views
3K
Anonymous
Replies
82
Views
5K
Anonymous
Replies
3
Views
653
Anonymous